John David Horowitz
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Atrial Fibrillation Management and Outcomes
- Takotsubo Cardiomyopathy and Associated Phenomena
- Heart Failure Treatment and Management
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Takotsubo Cardiomyopathy and Associated Phenomena 60
- Heart Failure Treatment and Management 48
- Cardiac electrophysiology and arrhythmias 43
- Cardiovascular Function and Risk Factors 39
- Atrial Fibrillation Management and Outcomes 33
- Antiplatelet Therapy and Cardiovascular Diseases 29
- Physiology 79
- Nitric Oxide and Endothelin Effects 71
- Co-authors
- Simon Stewart (40 shared papers)Yuliy Y. Chirkov (70 shared papers)Sue Pearson (4 shared papers)Michael Paul Frenneaux (36 shared papers)John Francis Beltrame (18 shared papers)John E. Marley (1 shared paper)Aaron Leonid Sverdlov (41 shared papers)John George Franklin Cleland (6 shared papers)
- Journals
- Circulation (21 papers)International Journal of Cardiology (19 papers)Journal of the American College of Cardiology (19 papers)Journal of Cardiovascular Pharmacology (18 papers)Cardiovascular Drugs and Therapy (15 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
John David Horowitz
435 papers receiving 24.5k citations
John David Horowitz's Hit Papers
Peers
Comparison fields: 5 of 183
- Cardiology and Cardiovascular Medicine 17.3k
- Internal Medicine 2.4k
- Radiology, Nuclear Medicine and Imaging 2.6k
- Geriatrics and Gerontology 323
- Family Practice 153
Countries citing papers authored by John David Horowitz
This map shows the geographic impact of John David Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John David Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John David Horowitz more than expected).
Fields of papers citing papers by John David Horowitz
This network shows the impact of papers produced by John David Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John David Horowitz. The network helps show where John David Horowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside John David Horowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 444 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Apixaban versus Warfarin in Patients with Atrial Fibrillation Hit paper breakdown → | 2011 | 7049 |
| 2 | International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology Hit paper breakdown → | 2018 | 1093 |
| 3 | Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure Hit paper breakdown → | 1999 | 959 |
| 4 | International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management Hit paper breakdown → | 2018 | 615 |
| 5 | 1999 | 531 | |
| 6 | 1998 | 386 | |
| 7 | 2010 | 379 | |
| 8 | 2005 | 304 | |
| 9 | 2000 | 273 | |
| 10 | 2014 | 268 | |
| 11 | 2018 | 268 | |
| 12 | 2002 | 251 | |
| 13 | 2002 | 249 | |
| 14 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 239 |
| 15 | 2014 | 224 | |
| 16 | 1999 | 223 | |
| 17 | 2013 | 205 | |
| 18 | 1996 | 188 | |
| 19 | 2013 | 181 | |
| 20 | 2012 | 169 |
About John David Horowitz
John David Horowitz is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Radiology, Nuclear Medicine and Imaging, Pharmacology and Surgery, having authored 444 papers that have together received 25.9k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (71 papers), Takotsubo Cardiomyopathy and Associated Phenomena (60 papers), Cardiac Imaging and Diagnostics (53 papers), Heart Failure Treatment and Management (48 papers), Cardiac electrophysiology and arrhythmias (43 papers), Cardiovascular Function and Risk Factors (39 papers), Atrial Fibrillation Management and Outcomes (33 papers) and Antiplatelet Therapy and Cardiovascular Diseases (29 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (17.3k citations), Internal Medicine (2.4k citations), Radiology, Nuclear Medicine and Imaging (2.6k citations), Geriatrics and Gerontology (323 citations) and Family Practice (153 citations). John David Horowitz has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Simon Stewart, Yuliy Y. Chirkov, Sue Pearson, Michael Paul Frenneaux, John Francis Beltrame, John E. Marley, Aaron Leonid Sverdlov, John George Franklin Cleland, Barry M. Massie and Paul W. Armstrong. Their work appears in journals such as Circulation, International Journal of Cardiology, Journal of the American College of Cardiology, Journal of Cardiovascular Pharmacology and Cardiovascular Drugs and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.